Burns J W & Co. Inc. NY Sells 2,258 Shares of Zoetis Inc. $ZTS

Key Points

• Burns J W & Co. Inc. NY reduced its holdings in Zoetis Inc. by 14.0% in the second quarter, bringing their total shares down to 13,871 and valuing their stake at $2,163,000.
• Several hedge funds increased their positions in Zoetis, with Portside Wealth Group raising its stake by 24.7% and Tandem Investment Advisors increasing theirs by 100.3%, showcasing varying investment strategies among institutional investors.
• Zoetis reported an earnings per share (EPS) of $1.76 for the recent quarter, exceeding estimates and reflecting a 4.2% year-over-year revenue increase.

Burns J W & Co. Inc. NY reduced its holdings in shares of Zoetis Inc. (NYSE:ZTS - Free Report) by 14.0% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,871 shares of the company's stock after selling 2,258 shares during the quarter. Burns J W & Co. Inc. NY's holdings in Zoetis were worth $2,163,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Security National Bank lifted its stake in Zoetis by 2.8% in the second quarter. Security National Bank now owns 51,425 shares of the company's stock valued at $8,020,000 after buying an additional 1,385 shares during the last quarter. Rockland Trust Co. raised its holdings in shares of Zoetis by 10.1% during the second quarter. Rockland Trust Co. now owns 7,025 shares of the company's stock valued at $1,096,000 after acquiring an additional 646 shares during the period. Exchange Traded Concepts LLC raised its position in Zoetis by 6.0% during the second quarter. Exchange Traded Concepts LLC now owns 8,383 shares of the company's stock valued at $1,307,000 after buying an additional 474 shares during the period. Marshall Financial Group LLC increased its stake in Zoetis by 11.9% in the 2nd quarter. Marshall Financial Group LLC now owns 11,124 shares of the company's stock valued at $1,747,000 after buying an additional 1,180 shares during the period. Finally, Vista Investment Partners LLC increased its holdings in Zoetis by 0.4% in the second quarter. Vista Investment Partners LLC now owns 24,925 shares of the company's stock worth $3,887,000 after buying an additional 104 shares during the last quarter. Hedge funds and other institutional investors own 92.80% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on ZTS. Argus reiterated a "buy" rating and set a $190.00 target price on shares of Zoetis in a research report on Tuesday, September 9th. Leerink Partners downgraded Zoetis from an "outperform" rating to a "market perform" rating and reduced their price target for the stock from $180.00 to $155.00 in a research report on Thursday, July 17th. Leerink Partnrs downgraded shares of Zoetis from a "strong-buy" rating to a "hold" rating in a research report on Thursday, July 17th. Piper Sandler increased their target price on shares of Zoetis from $210.00 to $215.00 and gave the company an "overweight" rating in a report on Monday, August 11th. Finally, Stifel Nicolaus cut shares of Zoetis from a "buy" rating to a "hold" rating and reduced their price objective for the company from $165.00 to $160.00 in a research note on Wednesday, June 18th. Five investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $200.88.

Zoetis Stock Performance

NYSE ZTS traded down $0.62 during trading on Tuesday, reaching $144.03. The company's stock had a trading volume of 710,428 shares, compared to its average volume of 3,018,963. Zoetis Inc. has a twelve month low of $139.70 and a twelve month high of $197.51. The company has a debt-to-equity ratio of 1.05, a quick ratio of 1.04 and a current ratio of 1.76. The business's fifty day moving average price is $151.03 and its 200-day moving average price is $156.27. The firm has a market cap of $63.83 billion, a price-to-earnings ratio of 24.79, a P/E/G ratio of 2.34 and a beta of 0.88.

Zoetis (NYSE:ZTS - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $1.76 EPS for the quarter, beating analysts' consensus estimates of $1.62 by $0.14. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.The firm had revenue of $2.46 billion for the quarter, compared to analysts' expectations of $2.41 billion. During the same quarter in the prior year, the firm earned $1.56 EPS. Zoetis's quarterly revenue was up 4.2% on a year-over-year basis. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, analysts anticipate that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.